Description
CPT IQ200 URINALYSIS INSTRUMENTATION
First action · last action
2014-10-21 · 2016-01-28
Transactions
2
First transaction's obligation
$116,755
Base + all options value (sum of deltas)
$113,235
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P7090A
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-21+$116,755= $116,755
- Mod P000012016-01-28-$3,520= $113,235
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-21 | +$116,755 | $116,755 | CPT IQ200 URINALYSIS INSTRUMENTATION |
| Mod P00001· CHANGE ORDER | 2016-01-28 | −$3,520 | $113,235 | CPT IQ200 URINALYSIS INSTRUMENTATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under 6630 from 512-BALTIMORE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24515F0223 | ABBOTT LABORATORIES INC. | 512-BALTIMORE | $182,368 | FY2015 |
| VA24515F0062 | DIAGNOSTICA STAGO INC | 512-BALTIMORE | $74,026 | FY2015 |
| VA24515F0123 | WERFEN USA LLC | 512-BALTIMORE | $75,776 | FY2015 |
| VA24514F2415 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 512-BALTIMORE | $8,992 | FY2014 |
| VA24514F1215 | SYSMEX AMERICA, INC | 512-BALTIMORE | $112,356 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24515F0203_3600_V797P7090A_3600 · retrieved 2026-09-26.